Browse

Nowadays, access to medicine is a crucial precondition for many disease prevention programmes and the treatment component of virtually all diseases. The availability of qualitative pharmaceutical care services is an integral part of the national welfare system, thus their quality maintenance and improvement under conditions of budget austerity is one of the main challenges for policy makers and pharmaceutical companies. The current research is a continuation of several related research projects implemented in scop...